Antimycobacterial neolignans isolated from Aristolochia taliscana

Antimycobacterial neolignans isolated from Aristolochia taliscana

Tuberculosis (TB - Mycobacterium tuberculosis) is an ancient infectious disease that has appeared once again as a serious worldwide health problem and now comprises the second leading cause of death resulting from a single infection. The prevalence of multidrug resistance (MDR) TB is increasing and...

Bibliografske podrobnosti
Main Authors:	Rosalba León-Díaz, Mariana Meckes, Salvador Said-Fernández, Gloria Maria Molina-Salinas, Javier Vargas-Villarreal, Javier Torres, Julieta Luna-Herrera, Adelina Jiménez-Arellanes
Format:	Article
Jezik:	English
Izdano:	Fundação Oswaldo Cruz (FIOCRUZ) 2010-02-01
Serija:	Memorias do Instituto Oswaldo Cruz
Teme:	antimycobacterial neolignans A. taliscana M. tuberculosis H37Rv MDR M. tuberculosis non-tuberculous mycobacteria
Online dostop:	http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0074-02762010000100006

Podobne knjige/članki

Antimycobacterial Activity of <i>Hedeoma drummondii</i> against <i>Mycobacterium tuberculosis</i> and Non-Tuberculous Mycobacteria
od: Carmen Molina-Torres, et al.
Izdano: (2023-04-01)

Assessment of Antimycobacterial Activity of Newly Synthesized Pyrimidine Derivatives Against Mycobacterium tuberculosis
od: M. A. Samotrueva, et al.
Izdano: (2022-08-01)

Synthesis and Antimycobacterial Assays of Some New Ethambutol Analogs
od: Rana Abdelaziz, et al.
Izdano: (2025-01-01)

Actividad antimicobacteriana de terpenos Antimycobacterial activity of terpenes
od: Juan Gabriel Bueno-Sánchez, et al.
Izdano: (2009-12-01)

Antimycobacterial Activity of Laurinterol and Aplysin from <i>Laurencia johnstonii</i>
od: Sara García-Davis, et al.
Izdano: (2020-05-01)

DETECTION AND DIFFERENTIATION OF NON-TUBERCULOUS MYCOBACTERIA AND M. TUBERCULOSIS COMPLEX BY REAL TIME PCR
od: V. V. Ustinova, et al.
Izdano: (2016-09-01)

Detection of Mtb and NTM: preclinical validation of a new asymmetric PCR-binary deoxyribozyme sensor assay
od: Yasmin Castillos das Neves, et al.
Izdano: (2024-06-01)

Chemical transformations of neolignans
od: Massayoshi Yoshida
Izdano: (1991-01-01)

DETECTION OF NON-TUBERCULOUS MYCOBACTERIA IN MARI EL REPUBLIC
od: L. V. Petrovа, et al.
Izdano: (2018-03-01)

PRECLINICAL STUDIES OF THE SPECIFIC ACTIVITY OF THE NEW ANTITUBERCULOSIS DRUG THIOZONIDE
od: I. V. Bocharova, et al.
Izdano: (2014-06-01)

Design, Synthesis, and Biological Evaluation of New Benzoxaborole Derivatives as Potential Antimycobacterial Agents
od: Petr Šlechta, et al.
Izdano: (2022-11-01)

<i>N</i>-Pyrazinoyl Substituted Amino Acids as Potential Antimycobacterial Agents—the Synthesis and Biological Evaluation of Enantiomers
od: Martin Juhás, et al.
Izdano: (2020-03-01)

A CLINICAL CASE OF EFFECTIVE TREATMENT OF EXTENSIVE DRUG RESISTANCE TUBERCULOSIS WITH NEW ANTI-TUBERCULOSIS DRUGS
od: M. V. Pаvlovа, et al.
Izdano: (2018-01-01)

A new in vitro dormancy model of <i>Mycobacterium tuberculosis</i>
od: Ya. R. Bаtyrshinа, et al.
Izdano: (2020-04-01)

Therapeutic Potential of Silver Nanoparticles (AgNPs) as an Antimycobacterial Agent: A Comprehensive Review
od: Nilakshi Barua, et al.
Izdano: (2024-11-01)

Implication of Negative GeneXpert Mycobacterium tuberculosis/Rifampicin Results in Suspected Tuberculosis Patients: A Research Study
od: Deby Kusumaningrum, et al.
Izdano: (2024-06-01)

Profile of non-tuberculous mycobacteria amongst tuberculosis presumptive people in Cameroon
od: Valerie Flore Donkeng Donfack, et al.
Izdano: (2024-03-01)

Seladoeneolignan A, a new neolignan from Selaginella doederleinii Hieron.
od: Minyu CHEN, et al.
Izdano: (2022-09-01)

Cytotoxicity and Antimycobacterial Properties of Pyrrolo[1,2-<i>a</i>]quinoline Derivatives: Molecular Target Identification and Molecular Docking Studies
od: Katharigatta N. Venugopala, et al.
Izdano: (2020-05-01)

Antimycobacterial activity of scopoletin from ethanolic extract of Hymenodictyon floribundum (Hochst. & Steud.) B.L.Rob. Stem bark
od: Alphonce Ignace Marealle, et al.
Izdano: (2023-09-01)

Plasma cytokine levels as markers of pathogenesis and treatment response in patients with non-tuberculous mycobacterial pulmonary disease
od: Sai Zhao, et al.
Izdano: (2024-09-01)

Impact of Vitamin D Supplementation in the Therapy Of Tuberculosis
od: Muhammadu Ibrahim Abdullah, et al.
Izdano: (2023-12-01)

Non-tuberculous mycobacteria: occurrence in skin test cattle reactors from official tuberculosis-free herds
od: Alberto Gomez-Buendia, et al.
Izdano: (2024-01-01)

Isolation of new neolignans and an unusual meroterpenoid from Piper cabagranum
od: Celso R. de Oliveira, et al.
Izdano: (2024-01-01)

Semisynthetic Derivatives of Selected Amaryllidaceae Alkaloids as a New Class of Antimycobacterial Agents
od: Negar Maafi, et al.
Izdano: (2021-10-01)

Clinical correlation study of non-tuberculous mycobacterial isolates from bronchoalveolar lavage fluid
od: Hongye Ning, et al.
Izdano: (2025-03-01)

EFFICIENCY OF CHEMOTHERAPY WITH BEDAQUILINE IN DRUG RESISTANT PULMONARY TUBERCULOSIS PATIENTS
od: A. M. Tikhonov, et al.
Izdano: (2018-03-01)

DETECTION OF TUBERCULOUS MYCOBACTERIA IN THE BLOOD OF PATIENTS WHEN SUSPECTING TUBERCULOUS SEPSIS
od: V. N. Zimina, et al.
Izdano: (2016-08-01)

New genetic biomarkers from transcriptome RNA-sequencing for Mycobacterium tuberculosis complex and Mycobacterium avium complex infections by bioinformatics analysis
od: Qingjun Jia, et al.
Izdano: (2024-07-01)

Isolation and Histopathological Changes Associated with Non-Tuberculous Mycobacteria in Lymph Nodes Condemned at a Bovine Slaughterhouse
od: Angélica M. Hernández-Jarguín, et al.
Izdano: (2020-11-01)

MONOPHENOL TS-13 improves SURVIVAL in MICE INFECTed with VIRULENT <i>M</i><i>ycobacterium tuberculosis</i>
od: P. M. Kozhin, et al.
Izdano: (2019-02-01)

Synthesis, Activity, Toxicity, and In Silico Studies of New Antimycobacterial <i>N</i>-Alkyl Nitrobenzamides
od: João P. Pais, et al.
Izdano: (2024-05-01)

In vitro photodynamic inactivation of Mycobacterium tuberculosis by methylene blue
od: D. A. Bredikhin, et al.
Izdano: (2019-08-01)

Prevalence and predictors of NTM in presumed/confirmed drug-resistant TB
od: E.T. Abbew, et al.
Izdano: (2024-07-01)

Anti-Inflamatory Activity of Neolignan Compound Isolated from the Roots of <i>Saururus chinensis</i>
od: Sae-Rom Yoo, et al.
Izdano: (2020-07-01)

<i>In Vitro</i> Antimycobacterial Activity of Human Lactoferrin-Derived Peptide, D-hLF 1-11, against Susceptible and Drug-Resistant <i>Mycobacterium tuberculosis</i> and Its Synergistic Effect with Rifampicin
od: Sorasak Intorasoot, et al.
Izdano: (2022-12-01)

High Vitamin D Concentrations Restore the Ability to Express LL37 by <i>M. tuberculosis</i>-Infected Human Macrophages
od: María Teresa Herrera, et al.
Izdano: (2022-02-01)

Multidrug-Resistant Mycobacterium tuberculosis in a Community Hospital, Luanda, Angola
od: Ngiambudulu M. Francisco, et al.
Izdano: (2025-03-01)

Miru-vntr technique for molecular epidemiological studies of tuberculosis
od: E. V. Аntusheva, et al.
Izdano: (2016-04-01)

IN VITRO PHOTODYNAMIC INACTIVATION OF MYCOBACTERIUM TUBERCULOSIS BY RADAHLORIN
od: D. A. Bredikhin, et al.
Izdano: (2018-01-01)